Glioma is a highly heterogeneous tumor with multiple genetic characteristics, including isocitrate dehydrogenase (IDH1) mutation, 1p/19q-deficiency, and O-6-methylguanine-DNA methyltransferase methylation (4). This evidence concerns the gene IDH1 and central nervous system cancer.